Evercore (EVR) Could Be 23% Below Fair Value On Global Growth Narrative

Evercore (EVR) is back in focus after the firm appointed John Pissanos as Senior Managing Director in its healthcare investment banking group, where he will focus on life science tools, diagnostics, and medtech from a London base.

Evercore’s latest executive hire comes at a tricky moment for the stock, with the share price down 8.5% over the past month and roughly 25% over the past quarter, even though the 3 year total shareholder return has roughly doubled investors’ capital.

Scan how Evercore compares with other advisory driven financial firms by reviewing a hand picked set of list of solid balance sheet and fundamentals (23 results).

Evercore has dropped sharply while analysts still see a wide gap between the current US$281.21 share price and their targets. Where does a fair value range really land within that spread, and how wide is the margin of error?

Most Popular Narrative: 23% Undervalued

Against Evercore’s last close at $281.21, the most followed narrative pegs fair value at $363.90, which frames the recent share pullback as a valuation disconnect rather than a simple loss of confidence.

The ongoing globalization of capital markets and an accelerating trend in cross-border M&A activity are providing an increasingly fertile environment for independent, conflict-free advisors like Evercore. The firm's continued expansion into key international markets, as evidenced by new offices and hiring in EMEA (France, Spain, Italy, Dubai, UK), positions it to capture an increasing share of growing advisory fee pools and drive top-line revenue over the long term.

See why 18 investors see Evercore as 23% undervalued.

Result: Fair Value of $363.90 (UNDERVALUED)

Still, that undervaluation story can unravel if Evercore’s high fixed and compensation costs squeeze margins further, or if advisory deal activity stays weaker for longer.

Find out about the key risks to this Evercore narrative.

Next Steps

If this Evercore narrative feels compelling, consider acting promptly and weigh the potential upside signals against your own risk tolerance. Start by reviewing the 3 key rewards.

Looking for more Evercore style investment ideas?

Do not stop with Evercore. Broaden your watchlist with focused screeners that surface different types of opportunities before they are crowded and harder to evaluate on your terms.

• Target income resilience by reviewing companies with steady payouts and sturdy fundamentals through the 6 dividend fortresses.
• Hunt for quality at a discount by scanning the 32 high quality undervalued stocks that combine solid cash flows with stronger balance sheets.
• Spot tomorrow's potential leaders early by checking the 15 high quality undiscovered gems that many investors may not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com